The Journal of the American Medical Association (JAMA) reported that the Adverse Events Reporting System (VAERS) reports that occurrence of anaphylaxis from the COVID-19 Vaccines is “4.7 cases/million Pfizer-BioNTech vaccine doses administered and 2.5 cases/million Moderna vaccine doses administered, based on information through January 18, 2021.”
In a March 30, 2021 posting, the CDC reported similar statistics alleging that “[a]naphylaxis after COVID-19 vaccination is rare and occurred in approximately 2 to 5 people per million vaccinated in the United States based on events reported to VAERS.” (bold emphasis in original)
The problem with that reports from JAMA and the CDC is that they are contradicted by another, more recent, March 8, 2021 report from JAMA. That study of Mass General Brigham (MGB) employees receiving COVID-19 vaccines, was published by the JAMA reveals that “severe reactions consistent with anaphylaxis occurred at a rate of 2.47 per 10,000 vaccinations.”
Siri and Brehma pointed out that the MGB study reveals that the VAERS is under-reporting the accounts of anaphylaxis from the COVID-19 vaccines by a factor of between 50 and 120 times. ICAN complained that “[t]he underreporting of anaphylaxis by the CDC and VAERS is particularly troubling because it is mandatory for medical providers to report anaphylaxis after any COVID-19 vaccine to VAERS.”
The most salient point in the letter from ICAN is the revelation from the MGB study that “the rate of reporting [of COVID-19 vaccine anaphylaxis adverse reactions] still appears to be only around 0.8 to 2 percent of all cases of anaphylaxis.”
The ICAN letter goes on to point out the obvious:
This raises serious concerns regarding (1) under-reporting of other serious adverse events following COVID-19 vaccination, and (2) adverse events following other vaccines for which there has not been the same push to report adverse events. The anaphylaxis study highlights the urgency of the ongoing, well-known problem with adverse event reporting post-vaccination.
The recent MGB study confirms the previous study done by Harvard that indicated that “fewer than 1% of vaccine adverse events” are reported in the VAERS system. Thus you can take any statistic from the VAERS system and multiply it by 100 and you will have a better idea of the real number for that category of adverse events. Thus, deaths reported under VAERS would likely be subject to the same under-reporting as would anaphylaxis. As with anaphylaxis, we can expect that only 1% of all deaths from COVID-19 vaccines are being reported in the VAERS system.
For example, as of March 26, 2021, VAERS reported 50,716 adverse events from the COVID-19 vaccines, which included 1,785 deaths. Thus, according to VAERS, 3.5% of all COVID-19 adverse events were deaths.
Assuming the numbers reported in VAERS represent only 1% of the actual deaths, as of March 26, 2021, we can extrapolate that the actual number of deaths from COVID-19 vaccines would likely be 178,500. In like manner, the actual total number of adverse events from COVID-19 vaccines would likely be 5,071,600.